Align Chiropractic Medicare Supplier Location: 1003 E Reelfoot Ave, Union City, Tennessee 38261 Phone: (731) 885-0461 |
Drs Denaburg And Jordan Medicare Supplier Location: 622 E Reelfoot Avenue, Union City, Tennessee 38261 Phone: (731) 885-0541 |
Hanger Clinic Durable Medical Equipment & Medical Supplies Location: 1313 W Reelfoot Ave, Union City, Tennessee 38261 Phone: (731) 437-2007 |
Human Technology Inc Medicare Supplier Location: 701 E Reelfoot Ave, Union City, Tennessee 38261 Phone: (731) 884-0284 |
Kizer Pharmacy Long Term Care Pharmacy Location: 1117 S Miles Ave, Union City, Tennessee 38261 Phone: (731) 885-2226 |
Union City Eye Care Pc Medicare Supplier Location: 1022 S Miles Ave, Union City, Tennessee 38261 Phone: (731) 885-1049 |
Wal-mart Pharmacy 10-0675 Durable Medical Equipment & Medical Supplies Location: 1601 W Reelfoot Ave, Union City, Tennessee 38261 Phone: (731) 885-6498 |
Walgreens #7983 Durable Medical Equipment & Medical Supplies Location: 700 E Reelfoot Ave, Union City, Tennessee 38261 Phone: (731) 884-1223 |
News Archive
Medivir AB, a research-based specialty pharmaceutical company focused on infectious diseases, today announced that it has signed an agreement with Daewoong Pharmaceutical Co. Ltd. to exclusively distribute Medivir's unique cold sore treatment Xerclear in China and Hong Kong.
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2012.
Jon O'Brien, president of Catholics for Choice, issued the following statement after Pope Benedict XVI acknowledged that condoms have a role to play in preventing the transmission of HIV: We are delighted that the pope has acknowledged that condoms can help reduce the risk of sexually transmitted infections including HIV. It is a marvelous victory for common sense and reason and a major step forward towards recognizing that condom use can play a vital role in reducing the future impact of the HIV pandemic.
Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announced that the European Medicines Agency accepted for review, the marketing authorization application (MAA) for anamorelin HCI, a novel, orally active selective ghrelin receptor agonist under development for the treatment of anorexia, cachexia, or unintended weight loss in non-small cell lung cancer (NSCLC) patients.
LinkMed decided to change the strategic focus of its operations, putting further focus on the transplantation sector, while intensifying and accelerating efforts to harvest the value of its associated companies. The change in strategy resulted in restructuring costs of SEK 6.3 million, charged to earnings in the third quarter. The restructuring carried out so far will result in an annual decrease in costs of SEK 7 million.
› Verified 6 days ago